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Abstract 
Organ printing technology or robotic additive biofabrication of 3D functional tissue and organ constructs is based on using tissue 
spheroids as building blocks. In order to bioprint human organs it is necessary to develop technology for scalable production of 
millions tissue spheroids. Ideally, these tissue spheroids must have standard size and shape suitable for bioprinting process.  The 
scalable biofabrication of large volume of standard size tissue spheroids could be achieved only by maximal employment of 
robotics and automation technologies. The three main competing groups of emerging tissue spheroid biofabrication technologies 
include: i) modified handing drop method, 2) molded non-adhesive hydrogel technology and iii) digital microfluidic technologies. 
The comparative analysis of emerging scalable tissue spheroid biofabrication technologies has been performed. Our data indicates 
that all these technologies have potential for robotization and automation. The molded non-adhesive hydrogel technologies provide 
best outcome for standardization of tissue spheroid size.  The microfluidics technology has strong advantage in accelerating of 
tissue spheroids biofabrication (theoretically, up to 10 000 droplets per second). New emerging approaches for biofabrication tissue 
spheroid using nanopatterned biomimetic surface and technologies for tissue spheroid encapsulation and functionalization will be 
also presented. The tissue spheroid biofabrication technologies are still evolving and represent hot area in biofabrication research. 
Moreover, these technologies are already subject of ongoing commercialization. Thus, it is safe to predict that scalable robotic 
tissue spheroid biofabricators must be integrated parts of organ biofabrication line. 
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1. Introduction 
Organ printing is a computer-aided robotic layer by 
layer additive biofabrication using living tissue 
spheroids as building blocks. [1-4]  The fundamental 
biophysical principle of organ printing technology is 
intrinsic capacity of tissue spheroid for tissue fusion 
driven by surface tension forces. Tissue fusion is an 
ubiquitous process during the embryonic development. 
Implementation of organ printing is not possible without 
development of technology for large scale production of 
living tissue spheroids. Thus, robotic biofabrication of 
self-assembling tissue spheroids at large scale is an 
important technological imperative. 
 
2. Why tissue spheroids? 
2.1. Tissue spheroids as building blocks 
Tissue spheroids have the small size and ideal 
geometric form for bioprinting. Tissue spheroids are 
formed by cell aggregation and have the maximal 
possible initial cell density. They have an intrinsic 
capacity for tissue fusion which make them an ideal 
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building material or some sort of living building blocks.
They can have complex composition and be pre-
vascularized. Most importantly, as it will shown here
tissue spheroids could be produced automatically using
robots in large amounts and of uniform size and shape
[4].
2.2. How many tissue spheroids are necessary in order 
to print human organ?
If we assume that the approximate size of average
adult human kidney is 100 mm x 50 mm x 50 mm then 
the estimated volume of such human organ will be 250
000 mm3. If we assume that average diameter of tissue
spheroid is 0,2 mm or 200 micrometers the in order to
bioprinter human organ of kidney size we must
biofabricate 6.250.000 (6,25 mln) of tissue spheroids. It 
have been reported recently that it is possible to
robotically biofabricate using non-adhesive molds 
placed in standard 96 multiwells up to 5000 tissue
spheroids per multiwall. Thus, we will need 1.250
multiwells with 5000 tissue spheroid in each in order to 
bioprint one human organ. It is also conceivable that one
middle size dispensing robot can effectively handle
approximately up to 50 multiwells. If it will be that case
then in order to robotically biofabricate one human
organ we will need just 5 dispensing robots which can
produce 250 multiwells. This simple calculation
demonstrates that even at recent level of technology 
development the transition from low scale laboratory 
method of biofabrication to large scale industrial 
biofabrication of tissue spheroids in desirable volume is
technologically feasible. We must not forget that 
commercially available robotic fluid dispensor and 
multiwall handling robots are also of the different scale.
Robotic fluid dispensor will be able to produce enough
tissue spheroid for bioprinting human organ like kidney.
2.3. Material properties of tissue spheroids.
Why it is important to know material properties of 
tissue spheroids? The material properties of the tissue
spheroids are essential to know because of several
reasons. Firstly, capacity of tissue spheroids to undergo
tissue fusion directly depends on their material
properties. The more rigid tissue spheroid fuses more
slowly. The level of maturation of tissue spheroids such
as chondrospheres and osteospheres is manifested in 
their material properties and could be used as one of 
objective criteria of their functional maturation.
Materiall propertis of tissue spheroid could be also used
for their standardization. Finally, if tissue spheroid is a
building block [4] or even is a specific living form of 
biomaterial [5] and we want to build complex 
construction like human organ, it is not a bad idea to
know what are the material properties of building
material.
To measure quantitatively and precisely the material
properties of tissue spheroid is not a trivial thing.
However, there are already several approaches for study 
material properties of tissue spheroids which have been 
developed and successfully implemented (Figure 1).
Fig. 1. Methods of measurement of material properties of tissue
spheroids. a) tensiometry; b) aspiration; c) spreading; d) microfluidics
based squeezing.
Historically the compression of living tissue spheroid
using parallel plate or tensiometer was one of the first 
method of quantitative estimation of their material
properties [6]. However, it is subject of some criticism 
now because technology of measurement is based on
some unconfirmed assumptions [7]. More recently 
aspiration assay is becoming increasingly popular for 
study tissue spheroid [8]. However, measurement by
aspiration assay reflects more local material properties
rather than desirable global material properties. Another 
method is based on tissue spheroids spreading [9].
Finally, recently simple and elegant microfluidics
method for study tissue spheroid material properties
have been developed and experimentally tested [10].
Microfluidics method as well as indirect method based 
on non-invasive but carefully calibrated impedance
measurements could be employed for high throughput 
screening of tissue maturation factors and also for 
quality control of tissue spheroid at industrial scale.
3. Method of scalable robotic biofabrication of tissue
spheroids
3.1. Modified hanging drop methods.
Handing drop method is a classic biological method
which was used by Prof. Aleksander Maximow as some
sort of minibioreactor for cell culturing in the beginning
of XX century. According our personal experience the
main limitation of hanging drop method was low
reproducibility due to satellite formation and laborious
handling. However, two companies InSphero and 3D
Biomatrix recently modified this method by making
hanging drop droppable and thus allow applying robotic
automated dispensing (Figure 2) [11,12].
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Fig. 2. Hanging drop method of scalable biofabrication of tissue
spheroids. a) scheme of the method ; b) robotic fluid dispenser.
3.2. Non-adhesive molded hydrogel.
Non-adhesive hydrogel molding has been 
commercialized by Brown University start-up company
[13]. It is also gravity based approach 
and it is based placing cell suspension into
microrecession in non-adhesive agarose hydrogel. We
recently modified this method by using more dense mold 
and robotization approach [14] (Figure 3).
3.3. Digital microfluidics.
Digital microfluidics based method of scalable
biofabrication of tissue spheroids theoretically can
produce up to 10 000 spheroids per second. Coaxial
droplet generator has been developed and tested [15]. 
thus, digital microfluidics is one of most perspective
method of scalable biofabrication of tissue spheroids.
However, the issue of low cell density in hydrogel
droplets generated by microfluidics droplet generating
devices must be addressed and technology must be
optimized (Figure 4).
3.4. Tissue spheroids biofabricating companies
One of the best objective indicators of the maturation
of any technology is initiation of technology transfer or 
commercialization of technology. Both modified
hanging drop method and non-adhesive hydrogel
molding method of tissue spheroid biofabrication have
been commercialized. It is safe to predict that 
microfluidics will be next. There are some tissue
spheroids such as chondrospheres and cardiospheres
which are already in clinical trial (Table 1).
Fig. 3. Scalable robotic biofabrication of tissue spheroids using non-
adhesive hydrogel molding technology. a) mold ; b) scheme of the
method; c) robotic fluid dispenser (EpMotion-5075, Eppendorf, 
Germany).
3.5. Novel emerging methods of tissue spheroids
biofabrication
The improvement of tissue spheroid biofabrication is
ongoing process. Recently, several interesting 
approaches for biofabrication of tissue spheroids based
on creative employment of novel physical and chemical
principles have been developed which include using
thermo-reversible hydrogel [16], cell surface
modification [17], dielectrophoresis [18], magnetic
levitation [19], nanopatterned surface like pillared sheet 
based on biomimetic principle of so-
[20]. It clearly reflects the ongoing progress in the 
development of novel more sophisticated method of 
tissue spheroid biofabrication. However, from the
position of criteria of scalability not all of these
sophisticated methods have been proven potentially
useful or suitable for clinical translation and not all have
strong potential for scaling up. For example, because of 
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single cell level precision and elegant simplicity of 
dielectropheresis principle deserves special attention.
The emerging nanotechnology such as nanopatterned
pillared sheet and patterned nanosurface from thermo-
sensitive hydrogel could be also scalable because surface
area coated with attachment permissive and thermo-
reversible hydrogel can control number of attached cells.
From another side, using sophisticated method of cell 
surface engineering and cell modification with DNA
doubly could be clinically relevant method as well as
method based on intensive using nanoparticles or other 
potentially toxic nanomaterials for cell levitation and
scalable production of clinically relevant tissue
spheroids.
Fig. 4. Scalable biofabrication of tissue spheroids using digital 
microfluidics. a) digital microfluidics based on droplet generator; b)
scheme of the digital microfluidics based droplet generator developed 
at CTI; c) digital microfluidics based coaxial droplet generator 
(10).
Table 1. Some commercial tissue spheroids biofabricating companies.
Company Name Country Method
3D BioMatrix USA Hanging Drop
Microtissue USA Mold
InSphero Switzerland Hanging Drop
CyFuse Japan Hanging Drop
Co.don Germany Hanging Drop
4. Post-fabrication processing: functionalization and 
cryopreservation of tissue spheroids
4.1. Cryopreservation of tissue spheroids
This issue is still under discussion and there is no
clear consensus between researchers - do we need to
develop cryopreservation technology for long term 
storage and transportation of biofabricated tissue
spheroids or they must be fabricated only locally (ideally 
inside hospital or even operation room) and used for 
organ printing only freshly fabricated. It is a complex
biological, technological and also economic question 
and heavily based on using only autologous or also
allogeneic cells, using integrated or separated robotic
systems, and selected centralized or decentralized (local)
business model. What is important from biological and
biotechnological point of view that the efficient 
cryopreservation technologies with clinically relevant 
and sufficient level of viability of tissue spheroids after 
thawing have been already developed.
4.2. Harvesting and translocation of tissue spheroids
Tissue spheroids as so-
bioprinter, which automatically implies that from 
technological point of view the bioprinter must have
either cartridge loaded with bioink like desktop inkjet 
printers or it must have a direct connections with
multiwells or digital microfluidics systems which 
biofabricate tissue spheroids. In first case scenario we 
must developed cartridge and probably deal with
cryopreserved tissue spheroids. In second case scenario
we must develop effective methods of translocation of 
freshly biofabricated tissue spheroids directly into
bioprinter dispensing head or nozzle. More traditional 
pressurized or gravity based approaches could be and
must be initially explored on feasibility. However, 
possible technological platforms exploring acoustic,
electric and magnetic levitation of tissue spheroids as the
way of their rapid translocation and dispensing in robotic
bioprinter also deserves special attention and systematic 
exploration on feasibility of such approaches.
Only one original paper was specially devoted to issue
of harvesting and it have been reported the method of 
tissue spheroids harvesting based on squeezing hydrogel
where microrecession for biofabrication of tissue
spheroid have been made. Another advantage of this 
method that is potentially suitable for highly desirable
automation and robotization [21].
In any case, tissue spheroids translocation from zone 
of their biofabrication toward bioprinter is not a trivial
biological and engineering task and still basically either 
ignored or just overlooked.
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4.3. Functionalization of tissue spheroids. 
 
Functionalization of tissue spheroids is directly 
related to their storage in cartridge and movement or 
translocation. In order to prevent preliminary and 
undesirable tissue spheroid fusion in cartridge during 
bioprinting process they must be encapsulated in highly 
non-adhesive and lubrificated hydrogel such as 
hyaluronan which is usually used for coating 
endovascular device for interventional cardiology. There 
are several commercial companies producing 
encapsulators. The commercial encapsulators have been 
initially designed for immunoisolation of pancreatic 
islands but they could be also relatively easy adapted for 
encapsulation of not natural but biofabricated tissue 
spheroids in desirable non-adhesive and lubricating 
hydrogel.  
 The second aspect of tissue spheroid 
functionalization is providing them with additional 
properties suitable for their translocation. For example, 
tissue spheroid could be either encapsulated into 
hydrogel containing magnetic nanoparticles or it could 
be encage in microscaffold also loaded with magnetic 
nanoparticles. In both case functionalization of tissue 
spheroid enables their magnetic levitation. 
We recently developed a design concept of encaging 
tissue spheroids into interlockable microscaffold or 
functionality - they enable rapid bottom up bioassembly 
of cartilage or bone tissue from tissue spheroids. 
Lockyballs enable tissue spheroid retention and maintain 
shape of 3D construct and tissue spheroid will later fuse 
and form tissue. 
Finally, functionalization of tissue spheroid could be 
directly related with tissue assembly process during 
bioprinting. For example, tissue spheroids encapsulated 
in hydrogel loaded with thrombin will be very easy and 
practically instantly be sintered by spraying fibrinogen 
solution and formation of fibrin hydrogel which will 
work as glue. 
5. Some misconceptions about tissue spheroids based 
organ printing technology. 
There are three main misconceptions about tissue 
spheroids in context of their using as building blocks in 
organ printing technology. First misconception is about 
revolutional novelty of solid scaffold free approach in 
tissue engineering, second misconception is about 
practical feasibility of organ printing technology and 
associated  still persistent believe that organ printing is 
either still in science fiction domain or in infancy state. 
Finally he is misconception about principal 
incompatibility between solid scaffold and solid scaffold 
free approach in tissue engineering. Using polymer and 
hydrogel for 3D printing or rapid prototyping of 
acellular synthetic scaffolds is not an organ printing. 3D 
printing of cells suspended in hydrogel with low cell 
density is also not an organ printing. Organ printing is 
layer by layer deposition of tissue spheroid which can 
fused and which have maximal possible initial cell 
density. Now let consider issue of feasibility. Could 
situation when there are already at least five commercial 
companies in different countries around the world 
producing tissue spheroids and there are already five 
companies producing robotic bioprinters be defined such 
term as  science fiction doma
 In really we are already 
facing dramatic translation from research to 
commercialization. Finally, is it possible to find 
compromise or common ground between traditional 
solid scaffold based tissue engineering approach and 
relatively new bottom-up modular microtissue based 
tissue engineering or it is completely incompatible 
research direction.  Our concept of tissue spheroid 
encaged in interlockable solid microscaffold or 
question. The lockyball concept allows combining all 
biomimetic advantages of tissue spheroids approach with 
advantage of solid-scaffold based approach. However, it 
is important to underline that basic fundamental 
principle of bottom up approach is not compromised. 
Tissue spheroid encaged in solid interlockable 
microscaffold and encapsulated in think layer of 
lubricating hydrogel could be used for bioprinting.  
It is also very important to indicate that tissue 
spheroid could have complex internal structure and 
composition and be pre-vascularized and prebuild in 
with high level of histological authenticity [22]. Finally, 
tissue spheroid could be printed together with solid or 
hydrogel scaffold and thus be incorporated into 3D solid 
scaffold of bioprinted cell-free hydrogel woodpile [23]. 
6. Conclusion 
Thus, presented data strongly indicate that scalable 
robotic biofabrication of tissue spheroids are not only 
technologically feasible but are already a subject of 
ongoing commercialization. It is a direct manifestation 
and reflection of general trend in biomedical 
robotizations and automation as the way to improve 
productivity and control the cost in biomedical industry. 
From another side, there are specific requirements for 
emerging bioprinting technology such as standardization 
of tissue spheroids size and shape, processibility, storage 
and large volumes which must be carefully addressed 
during development of new and optimization the 
existing scalable robotic biofabrication technology.  
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